Letter to the editor

Circulation Research

Volumn 97, Issue 12, 2005, Pages

  Bisoendial, Radjesh ^a   Birjmohun, Rakesh ^a   Keller, Tymen ^a   Van Leuven, Sander ^a   Levels, Han ^a   Levi, Marcel ^a   Kastelein, John ^a   Stroes, Erik ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; ENDOTOXIN; LIPOPOLYSACCHARIDE; RECOMBINANT PROTEIN;

AMYLOIDOSIS; ATHEROGENESIS; ATHEROSCLEROSIS; CONTAMINATION; HUMAN; IN VIVO STUDY; INFLAMMATION; LETTER; NONHUMAN; PRIORITY JOURNAL; CHEMICALLY INDUCED DISORDER; DRUG CONTAMINATION; NOTE;

C-REACTIVE PROTEIN; DRUG CONTAMINATION; ENDOTOXINS; HUMANS; INFLAMMATION; RECOMBINANT PROTEINS;

EID: 33644681377     PISSN: 00097330     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.RES.0000196746.75724.8b     Document Type: Letter

References (8)

1. Pepys MB, Hawkins PN, Kahan MC, Tennant GA, Gallimore JR, Graham D, Sabin CA, Zychlinsky A, Diego J de. Pro-inflammatory effects of bacterial recombinant human C-reactive protein are caused by contamination with bacterial products not by C-reactive protein itself. Circ Res. 2005;97:e97-e103.
2. Bisoendial RJ, Kastelein JJ, Levels JH, Zwaginga JJ, van den BB, Reitsma PH, Meijers JC, Hartman D, Levi M, Stroes ES. Activation of inflammation and coagulation after infusion of C-reactive protein in humans. Circ Res. 2005;96:714-716.
3. Haudek SB, Natmessnig BE, Redl H, Schlag G, Hatlen LE, Tobias PS. Isolation, partial characterization, and concentration in experimental sepsis of baboon lipopolysaccharide-binding protein. J Lab Clin Med. 2000;136:363-370.
4. Levi M, Ten Cate H, Bauer KA, van der PT, Edgington TS, Buller HR, Van Deventer SJ, Hack CE, ten Cate JW, Rosenberg RD. Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees. J Clin Invest. 1994;93:114-120.
5. Reifenberg K, Lehr HA, Baskal D, Wiese E, Schaefer SC, Black S, Samols D, Torzewski M, Lackner KJ, Husmann M, Blettner M, Bhakdi S. Role of C-reactive protein in atherogenesis: can the apolipoprotein E knockout mouse provide the answer? Arterioscler Thromb Vasc Biol. 2005;25:1641-1646.
6. Paul A, Ko KW, Li L, Yechoor V, McCrory MA, Szalai AJ, Chan L. C-reactive protein accelerates the progression of atherosclerosis in apolipoprotein E-deficient mice. Circulation. 2004;109:647-655.
7. Trion A, de Maat MP, Jukema JW, van der LA, Maas MC, Offerman EH, Havekes LM, Szalai AJ, Princen HM, Emeis JJ. No effect of C-reactive protein on early atherosclerosis development in apolipoprotein E*3-leiden/human C-reactive protein transgenic mice. Arterioscler Thromb Vasc Biol. 2005;25:1635-1640.
8. Falsey AR, Walsh EE, Francis CW, Looney RJ, Kolassa JE, Hall WJ, Abraham GN. Response of C-reactive protein and serum amyloid A to influenza A infection in older adults. J Infect Dis. 2001;183:995-999.